Brazil
University of São Paulo (USP) - Rheumatology Division
SARS-CoV-2, COVID-19, vaccine, HIV, immunogenicity, neutralizing antibodies, CoronaVac
autoimmune rheumatic diseases, COVID-19, vaccine, seropositive, immunogenicity